You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patients’characteristics – patients with no prior treatment (n = 32)

From: Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment

Characteristic n (%)
Tumor stage
 cT1c 6 (18.8)
 cT2a 1 (3.1)
 cT2b 3 (9.4)
 cT2c 4 (12.5)
 cT3a 5 (15.6)
 cT3b 3 (9.4)
 Tx 6 (18.8)
 cN1 32 (100)
 cM0 30 (93.75)
 cM1a 1 (3.1)
 cM1b 0
D’Amico risk group
 Low 2 (6.3)
 Intermediate 4 (12.5)
 High 26 (81.25)
Initial PSA level (ng/ml)
 Mean 32.78
 Median 21.71
 Range 5.1–198.0
PSA at the time of PET/CT (ng/ml)
 Mean 22.7
 Median 12.5
 Range 0.03–99.0
Gleason score
 ≤6 7 (21.88)
 7 (3 + 4) 3 (9.4)
 7 (4 + 3) 4 (12.5)
 8 1 (3.1)
 9 8 (25.0)
 missing 9 (28.1)
Age (years)
 Mean 69.2
 Median 71
 Range 51–80
Time from initial diagnosis until PET/CT (months)
 Mean 10.8
 Median 1
 Range 0–83